The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system

Colloids and Surfaces B: Biointerfaces

Volumn 103, Issue , 2013, Pages 174-181

  Zakeri Milani, Parvin ^a   Loveymi, Badir Delf ^b,c   Jelvehgari, Mitra ^d   Valizadeh, Hadi ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intestinal permeability; Nanoparticles; PLGA; SPIP; Vancomycin

Indexed keywords

BIODEGRADABLE NANOPARTICLE; CHEMICAL INTERACTIONS; CRYSTALLOGRAPHIC PROPERTIES; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; DRUG LOADING; ENTRAPMENT EFFICIENCY; ORAL ADMINISTRATION; PLGA; PLGA NANOPARTICLES; SOLVENT EVAPORATION METHOD; SPIP; VANCOMYCIN;

COPOLYMERS; DRUG DELIVERY; EMULSIFICATION; PARTICLE SIZE; ZETA POTENTIAL;

NANOPARTICLES;

NANOPARTICLE; POLYGLACTIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; INFRARED SPECTROSCOPY; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SOLVENT EFFECT; X RAY POWDER DIFFRACTION; ZETA POTENTIAL;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; COLLOIDS; DRUG DELIVERY SYSTEMS; INTESTINAL ABSORPTION; LACTIC ACID; MALE; NANOPARTICLES; PERMEABILITY; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VANCOMYCIN; X-RAY DIFFRACTION;

RATTUS;

EID: 84870207594     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.10.021     Document Type: Article

References (57)

1. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 1996, 13:1838.
2. Yu L., Zhou L., Ding M., Li J., Tan H., Fu Q., He X. Synthesis and characterization of novel biodegradable folate conjugated polyurethanes. J. Colloid Interface Sci. 2011, 358:376.
3. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci. 2010, 351:19.
4. Kumar G.S., Girija E.K., Thamizhavel A., Yokogawa Y., Kalkura S.N. Synthesis and characterization of bioactive hydroxyapatite-calcite nanocomposite for biomedical applications. J. Colloid Interface Sci. 2010, 349:56.
5. Nouvel C., Raynaud J., Marie E., Dellacherie E., Six J.L., Durand A. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers. J. Colloid Interface Sci. 2009, 330:337.
6. Hallaj-Nezhadi S., Valizadeh H., Dastmalchi S., Baradaran B., Jalali M.B., Dobakhti F., Lotfipour F. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells. J. Pharm. Pharm. Sci. 2011, 14:181.
7. DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., Posey L.M. Pharmacotherapy 2005, MCGRAW-HILL Medical Publishing Division, New York.
8. Han D.P., Wisniewski S.R., Wilson L.A., Barza M., Vine A.K., Doft B.H., Kelsey S.F. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am. J. Ophthalmol. 1996, 122:1.
9. Okochi H., Nakano M. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv. Drug Deliv. Rev. 2000, 45:5.
10. Pogue J.M., DePestel D.D., Kaul D.R., Khaled Y., Frame D.G. Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract. Transpl. Infect. Dis. 2009, 11:467.
11. Rao S., Kupfer Y., Pagala M., Chapnick E., Tessler S. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection. Scand. J. Infect. Dis. 2011, 43:386.
12. Damge C., Vranckx H., Balschmidt P., Couvreur P. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharm. Sci. 1997, 86:1403.
13. Mohammadi G., Valizadeh H., Barzegar-Jalali M., Lotfipour F., Adibkia K., Milani M., Azhdarzadeh M., Kiafar F., Nokhodchi A. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf. B 2010, 80:34.
14. Yang Y.-Y., Chung T.-S., Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22:231.
15. Muthu M.S. Nanoparticles based on PLGA and its co-polymer: an overview. Asian J. Pharm. 2009, 3:266.
16. Dunne M., Corrigan I., Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 2000, 21:1659.
17. Hachicha W., Kodjikian L., Fessi H. Preparation of vancomycin microparticles: importance of preparation parameters. Int. J. Pharm. 2006, 324:176.
18. Gavini E., Chetoni P., Cossu M., Alvarez M.G., Saettone M.F., Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur. J. Pharm. Biopharm. 2004, 57:207.
19. Sayin B., Atilla B., çaliş S., Marangoz S., Hincal A.A. In vivo evaluation of intraarticular vancomycin delivery following implantation of antibiotic loaded allografts and biopolymeric microparticules into bone defects. XXIII SICOT/SIROT Triennial World Congress 2005.
20. Valizadeh H., Zakeri-Milani P., Islambulchilar Z., Tajerzadeh H. A simple and rapid high-performance liquid chromatography method for determining furosemide, hydrochlorothiazide, and phenol red: applicability to intestinal permeability studies. J. AOAC Int. 2006, 89:88.
21. Zakeri-Milani P., Barzegar-Jalali M., Azimi M., Valizadeh H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Eur. J. Pharm. Biopharm. 2009, 73:102.
22. Zakeri-Milani P., Valizadeh H., Islambulchilar Z., Damani S., Mehtari M. Investigation of the intestinal permeability of ciclosporin using the in situ technique in rats and the relevance of P-glycoprotein. Arzneimittelforschung 2008, 58:188.
23. Zakeri-Milani P., Valizadeh H., Tajerzadeh H., Azarmi Y., Islambolchilar Z., Barzegar S., Barzegar-Jalali M. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J. Pharm. Pharm. Sci. 2007, 10:368.
24. Zakeri-Milani P., Valizadeh H., Tajerzadeh H., Islambulchilar Z. The utility of rat jejunal permeability for biopharmaceutics classification system. Drug Dev. Ind. Pharm. 2009, 35:1496.
25. Hasan A.S., Socha M., Lamprecht A., Ghazouani F.E., Sapin A., Hoffman M., Maincent P., Ubrich N. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int. J. Pharm. 2007, 344:53.
26. Hoffart V., Ubrich N., Simonin C., Babak V., Vigneron C., Hoffman M., Lecompte T., Maincent P. Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Dev. Ind. Pharm. 2002, 28:1091.
27. Zeta potential of colloids in water and waste water. ASTM Standard D 4187-82 1985, American Society for Testing and Materials, West Conshohocken, PA, USA.
28. Jelvehgari M., Zakeri-Milani P., Siahi-Shadbad M.R., Loveymi B.D., Nokhodchi A., Azari Z., Valizadeh H. Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights. AAPS PharmSciTech 2010, 11:1237.
29. Fagerholm U., Johansson M., Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 1996, 13:1336.
30. ® microspheres of stavudine. Trop. J. Pharm. Res. 2005, 4:369.
31. United States Pharmacopoeia and National Formulary (USP 31-NF26) 2008, Rockville, MD.
32. Moore J.W., Flanner H.H. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Tech. 1996, 20:64.
33. Alli S.M. Preparation and characterization of a coacervate extended-release microparticulate delivery system for Lactobacillus rhamnosus. Int. J. Nanomedicine 2011, 6:1699.
34. Alli S.M., Ali S.M., Samanta A. Development and evaluation of intestinal targeted mucoadhesive microspheres of Bacillus coagulans. Drug Dev. Ind. Pharm. 2011, 37:1329.
35. Sahoo N.G., Kakran M., Shaal L.A., Li L., Muller R.H., Pal M., Tan L.P. Preparation and characterization of quercetin nanocrystals. J. Pharm. Sci. 2011, 100:2379.
36. Zhang Y., Huo M., Zhou J., Zou A., Li W., Yao C., Xie S. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010, 12:263.
37. Costa P., Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13:123.
38. Azarmi S., Valizadeh H., Barzegar-Jalali M., Lobenberg R. In situ cross-linking of polyanionic polymers to sustain the drug release of Acetazolamide tablets. Pharm. Ind. 2003, 65:877.
39. Mohammadi G., Nokhodchi A., Barzegar-Jalali M., Lotfipour F., Adibkia K., Ehyaei N., Valizadeh H. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf. B 2011, 88:39.
40. Jelvehgari M., Milani P.Z., Siahi-Shadbad M.R., Monajjemzadeh F., Nokhodchi A., Azari Z., Valizadeh H. In vitro and in vivo evaluation of insulin microspheres containing protease inhibitor. Arzneimittelforschung 2011, 61:14.
41. Jelvehgari M., Barar J., Valizadeh H., Shadrou S., Nokhodchi A. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. Pharm. Dev. Technol. 2011, 16:637.
42. Barzegar-Jalali M., Adibkia K., Valizadeh H., Shadbad M.R., Nokhodchi A., Omidi Y., Mohammadi G., Nezhadi S.H., Hasan M. Kinetic analysis of drug release from nanoparticles. J. Pharm. Pharm. Sci. 2008, 11:167.
43. Azarmi S., Farid J., Nokhodchi A., Bahari-Saravi S.M., Valizadeh H. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. Int. J. Pharm. 2002, 246:171.
44. Capan Y., Jiang G., Giovagnoli S., Na K.H., DeLuca P.P. Preparation and characterization of poly(d,l-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS PharmSciTech 2003, 4:E28.
45. Wu J.C., Su S.G., Shyu S.S., Chen H. Effect of the solvent-non-solvent pairs on the surface morphology and release behaviour of ethylcellulose microcapsules prepared by non-solvent-addition phase separation method. J. Microencapsul. 1994, 11:297.
46. Thote A.J., Chappell J.T., Gupta R.B., Kumar R. Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs. Drug Dev. Ind. Pharm. 2005, 31:43.
47. Wickramasinghe R., Liow J.L., Leong Y.K. Nanobiotech Congress 2007.
48. Martin A., Bustamante P., Chun A.H. Physical Pharmacy and Pharmaceutical Sciences 2006, Lippincott Williams & Wilkins, Philadelphia. fifth edn.
49. Agnihotri S.M., Vavia P.R. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine 2009, 5:90.
50. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 1999, 57:171.
51. Averineni R.K., Shavi G.V., Gurram A.K., Deshpande P.B., Arumugam K., Maliyakkal N., Meka S.R., Nayanabhirama U. PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. B. Mater. Sci. 2012, 35:319.
52. Mukherjee B., Santra K., Pattnaik G., Ghosh S. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int. J. Nanomedicine 2008, 3:487.
53. de Chasteigner S., Fessi H., Devissaguet J.-P., Puisieux F. Comparative study of the association of itraconazole with colloidal drug carriers. Drug Dev. Res. 1996, 38:125.
54. Fonseca C., Simoes S., Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control. Release 2002, 83:273.
55. Ahlin P., Kristl J., Kristl A., Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int. J. Pharm. 2002, 239:113.
56. Hu K., Cao S., Hu F., Feng J. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int. J. Nanomedicine 2012, 7:3537.
57. He C., Yin L., Tang C., Yin C. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials 2012, 33:8569.